Rachel Borshchenko joined Teiko in 2022 and is currently a Business Development Manager, supporting biopharma partners with high-dimensional immune profiling. Prior to Teiko, she gained clinical research experience at UCSF and Mount Sinai. Rachel holds dual BAs in Biology and Jewish Ethics from Columbia University and the Jewish Theological Seminary.